Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

California Doctor Thomas F. Minahan, Director of Emergency Medicine, Supports Dr. Sanjay Gupta, CNN's Chief Medical Correspondent's Beliefs Regarding Medical Marijuana
  • USA - English


News provided by

YM & Associates PR | Marketing | Branding

Mar 19, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Minahan accompanies his daughter Mallory at a recent school formal function.  Mallory has been able to recently return to school after experiencing seizure relief from cannabis oil.
Dr. Minahan accompanies his daughter Mallory at a recent school formal function. Mallory has been able to recently return to school after experiencing seizure relief from cannabis oil.

Corona, CA (PRWEB) March 19, 2014 -- Doctor Thomas F. Minahan gives his 11 year-old daughter Mallory medical marijuana to treat her pediatric epilepsy. Faced with the difficult decision of giving her relatively harmless cannabis oil or a prescription drug that could potentially take her life, Dr. Minahan and his wife Carrin decided to challenge their conservative beliefs and give medical marijuana a try. “For us this isn’t a choice, it’s something we have to do,” said Dr. Minahan. “The results have been amazing.”

Over the past several months Mallory has displayed a mental clarity that has eluded her for most of her childhood. We feel like we finally have our daughter back. - Dr. Thomas F. Minahan

Post this

Director of Emergency Medicine and attending Physician at one of the busiest trauma centers in Southern California. Dr. Minahan is Board certified in Emergency Medicine and has been practicing for over 15 years. He knows firsthand the devastating effects of epilepsy as he has watched Mallory suffer from intractable (unsuccessfully treated) seizures since the age of fourteen months. “It breaks your heart as a parent, seeing your child suffer,” he says. As a physician, Dr. Minahan has watched in helpless frustration as varying treatments, specialty diets and prescription drugs have at first offered hope, only to end up failing in the end.

In 2013, their renowned epilepsy specialist suggested one last drug to try and stop the violent seizures but it could come at a cost. The medication had a possible side effect of shutting down Mallory’s bone marrow production and could result in her death. When asked if there were any other alternatives, the doctor said, “Well you could try cannabis, but there’s no scientific research that supports its effectiveness.” Coincidentally, around that time CNN aired a controversial special hosted by Dr. Sanjay Gupta touting success stories of children who were experiencing promising results from medical marijuana.

Very little scientific data exists in relation to the medicinal properties of cannabis as a treatment for epilepsy. What is theorized is that a chemical in the marijuana plant, Cannabidiol (known as CBD) has properties that help alleviate seizures in children. CBD is non-psychoactive, with almost no side effects.

The Minahans immediately saw positive results in their daughter’s reaction to the marijuana medication. “Within weeks, Mallory went from an average of 40 seizures a month to less than a dozen. Mallory has displayed a mental clarity that has eluded her for most of her childhood. We feel like we finally have our daughter back,” Dr. Minahan said. Since Mallory started her cannabis regimen, she has re-entered school and continues to flourish with improved mental alertness.

Deciding to go public with their story, the Minahan’s are trying to bring awareness to the need for research, development and potency regulation of the marijuana drug. “I absolutely DO NOT endorse cannabis as a drug to be used to get high,” Dr. Minahan said. “But that niche of people who could benefit medically from it deserve the scientific research and development it will take to ease their suffering,” he concluded.

The Minahan family has since created “Mallory’s Hope" as a conservative community forum and resource for parents who have children with seizures. “Mallory’s Hope” strives to educate the public and urge elected officials to allow legal research and development of cannabis-based medications. It supports content and potency regulation so that parents could be confident in consistently delivering proper dosage of marijuana medication to their children. “Overcoming the politics of pot is what is important now,” said Dr. Minahan. “The positive results seen in Mallory and countless other children demonstrate the importance of researching cannabis for its medicinal and healing properties."

Visit Mallory’s Hope at http://www.MallorysHope.com or follow Mallory’s Hope on Facebook at http://www.facebook.com/SupportMallorysHope.

Dr. Minahan is available for interviews and speaking engagements on the subject of pediatric epilepsy and can be reached at info(at)malloryshope(dot)org.

For media inquiries, interviews or speaking engagements, please contact Kelly Bennett at Kelly(at)BPUnlimited(dot)com or call 949-463-6383.

Kelly Bennett,
Bennett Productions Unlimited
(949) 463-6383
Kelly(at)BPUnlimited(dot)com
http://www.BPUnlimited.com
@KellyBPU

Yvette Morales, YM & Associates PR | Marketing | Branding, http://www.YM-PR.com, +1 (949) 244-9769, [email protected]

Modal title

Still shot from Dr. Minahan’s recently produced video promoting “Mallory’s Hope,” a conservative forum he and his wife have created supporting medicinal cannabis research and development.
Still shot from Dr. Minahan’s recently produced video promoting “Mallory’s Hope,” a conservative forum he and his wife have created supporting medicinal cannabis research and development.
Dr. Thomas F. Minahan and his wife Carrin were honored to meet conservative neurosurgeon Dr. Ben Carson at a speaking engagement.
Dr. Thomas F. Minahan and his wife Carrin were honored to meet conservative neurosurgeon Dr. Ben Carson at a speaking engagement.
Dr. Thomas F. Minahan is grateful for the reduction in seizures his daughter Mallory has experienced since taking cannabis oil.
Dr. Thomas F. Minahan is grateful for the reduction in seizures his daughter Mallory has experienced since taking cannabis oil.
Eleven year old Mallory Minahan has suffered from intractable seizure since she was fourteen months old.  She recently returned to school after her seizures were reduced with cannabis oil treatment.
Eleven year old Mallory Minahan has suffered from intractable seizure since she was fourteen months old. She recently returned to school after her seizures were reduced with cannabis oil treatment.
Dr. Thomas F. Minahan and his wife Carrin are the proud parents of four children, including eleven year old Mallory who suffers from intractable seizures.
Dr. Thomas F. Minahan and his wife Carrin are the proud parents of four children, including eleven year old Mallory who suffers from intractable seizures.
Dr. Thomas F. Minahan is Director of Emergency Medicine at one of Southern California’s busiest trauma centers.  He has recently found success treating his daughter with cannabis.
Dr. Thomas F. Minahan is Director of Emergency Medicine at one of Southern California’s busiest trauma centers. He has recently found success treating his daughter with cannabis.
Eleven year old Mallory Minahan has suffered from intractable seizures since she was fourteen months old.  Her seizures have been greatly reduced since beginning treatment with cannabis oil.
Eleven year old Mallory Minahan has suffered from intractable seizures since she was fourteen months old. Her seizures have been greatly reduced since beginning treatment with cannabis oil.
Mallory's Hope is a conservative forum and support resource seeking medicinal cannabis research and potency regulation toward the treatment and cure of pediatric seizures.
Mallory's Hope is a conservative forum and support resource seeking medicinal cannabis research and potency regulation toward the treatment and cure of pediatric seizures.
Dr. Thomas F. Minahan has committed to supporting cannabis research after seeing improvement in his daughter Mallory’s seizures since starting on cannabis oil.
Dr. Thomas F. Minahan has committed to supporting cannabis research after seeing improvement in his daughter Mallory’s seizures since starting on cannabis oil.
Still shot from Dr. Minahan’s recently produced video promoting “Mallory’s Hope,” a conservative forum he and his wife have created supporting medicinal cannabis research and development. Dr. Thomas F. Minahan and his wife Carrin were honored to meet conservative neurosurgeon Dr. Ben Carson at a speaking engagement. Dr. Thomas F. Minahan is grateful for the reduction in seizures his daughter Mallory has experienced since taking cannabis oil. Eleven year old Mallory Minahan has suffered from intractable seizure since she was fourteen months old.  She recently returned to school after her seizures were reduced with cannabis oil treatment. Dr. Thomas F. Minahan and his wife Carrin are the proud parents of four children, including eleven year old Mallory who suffers from intractable seizures. Dr. Thomas F. Minahan is Director of Emergency Medicine at one of Southern California’s busiest trauma centers.  He has recently found success treating his daughter with cannabis. Eleven year old Mallory Minahan has suffered from intractable seizures since she was fourteen months old.  Her seizures have been greatly reduced since beginning treatment with cannabis oil. Mallory's Hope is a conservative forum and support resource seeking medicinal cannabis research and potency regulation toward the treatment and cure of pediatric seizures. Dr. Thomas F. Minahan has committed to supporting cannabis research after seeing improvement in his daughter Mallory’s seizures since starting on cannabis oil.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.